Ipca Laboratories Q2 Results FY27: Revenue Down 11.77% to Rs 2,255.61 Cr, PAT Up 37.06% to Rs 387.29 Cr
- November 5, 2026
- Posted by: Harsh Piplani
- Category: Results
Quick Answer
Ipca Laboratories Q2 Results FY27 were declared on 5 November 2026, with revenue of Rs 2,255.61 Cr, down 11.77% YoY from Rs 2,556.5 Cr. Net profit came in at Rs 387.29 Cr against Rs 282.57 Cr a year earlier, a rise of 37.06%. These quarterly results show YoY growth in net profit alongside lower revenue.
Ipca Laboratories Ltd (IPCALAB) Q2 Results FY27 announced on 5 November 2026, covering the company’s financial performance for the July to September quarter. Revenue was Rs 2,255.61 Cr and PAT was Rs 387.29 Cr. The results date of 5 November 2026 puts Ipca Laboratories Q2 Results FY27 on record for the period, with the figures drawn from the latest filing.
This Ipca Laboratories Q2 Results analysis covers financial highlights, business drivers, outlook and risks. The results analysis starts with the financial highlights below, then reads revenue and net profit against the same quarter of last year.
Click Here – Get Free Investment Predictions
Ipca Laboratories Q2 Results FY27: Financial Highlights
| Metric | Q2 FY27 (Sep 26) | Q2 FY26 (Sep 25) | YoY Change |
|---|---|---|---|
| Revenue | Rs 2255.61 Cr | Rs 2556.5 Cr | -11.77% YoY |
| Net Profit (PAT) | Rs 387.29 Cr | Rs 282.57 Cr | +37.06% YoY |
Source: company filing for Ipca Laboratories Q2 Results FY27, 5 November 2026. Figures in Rs Crore.
Key Takeaways from Ipca Laboratories Q2 Results: What Stands Out
- Revenue of Rs 2,255.61 Cr fell 11.77% from Rs 2,556.5 Cr in the same quarter last year, a clear YoY decline.
- Net profit of Rs 387.29 Cr rose 37.06% from Rs 282.57 Cr, so profit moved against the direction of revenue.
- Net profit margin of 17.2% compares with 11.1% in the comparison quarter, so Ipca Laboratories Q2 Results FY27 show a wider margin.
- Revenue was down 19.1% quarter on quarter from Rs 2,788.10 Cr, while net profit was down 3.6% from Rs 401.89 Cr.
- Performance analysis next: the section below reads the YoY growth and net profit moves in more detail.
Ipca Laboratories Q2 Results FY27: Performance Analysis
Ipca Laboratories Q2 Results FY27 show revenue of Rs 2,255.61 Cr for the July to September 2026 quarter, down 11.77% YoY from Rs 2,556.5 Cr. Net profit was Rs 387.29 Cr against Rs 282.57 Cr in the comparison quarter, a rise of 37.06%, so profit grew while sales declined.
The net profit margin improved to 17.2% from 11.1%, which shows that net profit rose while revenue fell. In Ipca Laboratories Q2 Results FY27, the supplied figures confirm this move but do not establish the specific cause of the margin change.
Investors reading Ipca Laboratories Q2 Results will watch whether net profit holds near these levels in later quarterly results, since revenue fell 19.1% from the previous quarter. That profit strength is also the first of the business factors, which is where this results analysis turns next.
Check the Univest Screener for live results data
Key Business Factors This Quarter
Year on Year Net Profit Growth – The results analysis starts with net profit, which rose 37.1% year on year to Rs 387.29 Cr in the latest quarter. This rise from Rs 282.57 Cr is the largest positive movement among the reported lines.
Improved Net Profit Margin – Net profit margin improved to 17.2% from 11.1% in the comparison quarter. Ipca Laboratories Q2 Results FY27 therefore show a wider share of revenue reaching the bottom line, as part of the quarterly results.
Return Ratios in FY26 – Return on equity was 15.88% in FY26, and return on capital employed was 19.41%. These annual return figures sit alongside the quarter and give context to the net profit growth of 37.06% YoY.
FY27 Outlook After Ipca Laboratories Q2 Results
The FY27 outlook will be set by the quarters that follow. Full-year numbers depend on whether revenue recovers from Rs 2,255.61 Cr and how net profit compares with the Rs 387.29 Cr recorded here, and Ipca Laboratories Q2 Results FY27 provide the base for that comparison.
This results analysis also gives readers a yardstick. Net profit of Rs 282.57 Cr a year ago and Rs 387.29 Cr now mark the range against which later net profit prints will be judged, and Univest Screener users can follow those filings. The risks below sit on the same numbers.
Key Risks to Watch After Ipca Laboratories Q2 Results FY27
Revenue Decline Year on Year
Revenue declined 11.8% year on year to Rs 2,255.61 Cr in the latest quarter. Ipca Laboratories Q2 Results FY27 show sales below the Rs 2,556.5 Cr of the comparison quarter, so the YoY growth gap in revenue is a point to monitor.
Sequential Revenue Fall
Revenue was down 19.1% quarter on quarter from Rs 2,788.10 Cr. This sequential decline sits behind the YoY fall and makes the next quarter’s revenue an important number to follow in later results.
Sequential Dip in Net Profit
Net profit was down 3.6% quarter on quarter from Rs 401.89 Cr. Although net profit is up YoY, this small sequential dip is a figure to track alongside revenue in coming quarterly results.
Download the Univest iOS App or Univest Android App to track quarterly results as they are declared.
Conclusion
Ipca Laboratories Q2 Results FY27 show revenue of Rs 2,255.61 Cr, down 11.77% YoY, and net profit of Rs 387.29 Cr, up 37.06%. The margin improvement is the main positive in these quarterly results. The Ipca Laboratories Q2 Results revenue decline is the main point to monitor, and investors should consult a SEBI-registered advisor before acting.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice. Research Analyst: Uniresearch Global Pvt. Ltd., SEBI Registration No. INH000013776.
Frequently Asked Questions on Ipca Laboratories Q2 Results FY27
What are Ipca Laboratories Q2 Results FY27?
Ans. Ipca Laboratories Q2 Results FY27 are the quarterly results for July to September 2026, showing revenue of Rs 2,255.61 Cr and net profit of Rs 387.29 Cr, as summarised in the Quick Answer and the Financial Highlights table.
What is the results date for Ipca Laboratories Q2 Results FY27?
Ans. The results date for Ipca Laboratories Q2 Results FY27 was 5 November 2026, when Ipca Laboratories declared its numbers, so the Financial Highlights section reflects the filing made on that day.
What revenue was reported in Ipca Laboratories Q2 Results FY27?
Ans. Ipca Laboratories reported revenue of Rs 2,255.61 Cr in the quarter, compared with Rs 2,556.5 Cr a year earlier, which means revenue fell 11.77% as detailed in the Performance Analysis section.
What net profit was reported in Ipca Laboratories Q2 Results FY27?
Ans. Ipca Laboratories reported net profit of Rs 387.29 Cr for the quarter against Rs 282.57 Cr a year ago, so net profit rose 37.06% YoY, as discussed in the Key Takeaways section.
How much YoY growth did revenue show in Ipca Laboratories Q2 Results FY27?
Ans. Revenue showed YoY growth of minus 11.77%, falling from Rs 2,556.5 Cr to Rs 2,255.61 Cr, while net profit rose to Rs 387.29 Cr, as covered in the Performance Analysis section.
Did net profit rise or fall in Ipca Laboratories Q2 Results?
Ans. Net profit rose in Ipca Laboratories Q2 Results, climbing 37.06% YoY to Rs 387.29 Cr from Rs 282.57 Cr, which means the net profit margin improved to 17.2%, as explained in the Performance Analysis.
What was the net profit margin in Ipca Laboratories Q2 Results FY27?
Ans. The net profit margin was 17.2% against 11.1% in the comparison quarter, so profit took a larger share of revenue of Rs 2,255.61 Cr, as shown in the Key Business Factors section.
How much did net profit change YoY in Ipca Laboratories Q2 Results?
Ans. Net profit changed from Rs 282.57 Cr to Rs 387.29 Cr, a rise of 37.06% YoY, which means it moved against a revenue decline of 11.77%, as noted in the Financial Highlights.
What business factors shaped Ipca Laboratories Q2 Results FY27?
Ans. The key factors are 37.1% YoY net profit growth to Rs 387.29 Cr, the margin improvement to 17.2% and FY26 return ratios, as detailed in the Key Business Factors section.
What are the key risks after Ipca Laboratories Q2 Results FY27?
Ans. The key risks are the 11.8% YoY revenue decline, the 19.1% quarter on quarter revenue fall and a 3.6% sequential dip in net profit, as covered in the Key Risks section.
What is the outlook after Ipca Laboratories Q2 Results?
Ans. The FY27 outlook depends on later quarterly results, so full-year numbers will turn on revenue relative to Rs 2,255.61 Cr and net profit relative to Rs 387.29 Cr, as set out in the Outlook section.
Where can I find the complete Ipca Laboratories Q2 Results FY27 data?
Ans. The complete Ipca Laboratories Q2 Results FY27 data sits in the Financial Highlights table, and the Univest app and Univest Screener let readers track later Ipca Laboratories filings alongside this analysis.
